Y-mAbs Therapeutics
Presence
Y-mAbs Therapeutics is one of the...
Y-mAbs Therapeutics is a company listed under the stock ticker YMAB (US).
Executives
View the org chart displaying its 17 main executives
Most searched biographies at Y-mAbs Therapeutics
- Michael Rossi, President, Chief Executive Officer and Director
- Laura Hamill, Director
- Johan Wedell-Wedellsborg, Director
Popular executive movements at Y-mAbs Therapeutics
- Bo Kruse, who is Chief Financial Officer will soon leave the company (posted on March 14 2024).
- Mary Tagliaferri has joined the company as Director (posted on March 5 2024).
- Michael Rossi has joined the company as President, Chief Executive Officer and Director (posted on October 19 2023).
Create your alert
to follow the executive moves at Y-mAbs Therapeutics.
Biotechnology
Y-mAbs Therapeutics has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Y-mAbs Therapeutics
- Y-mAbs to Present at 2024 ASCO Annual Meeting | Y-mAbs Therapeutics, Inc.
- Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024 | Y-mAbs Therapeutics, Inc.
- Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer | Y-mAbs Therapeutics, Inc.
- Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors | Y-mAbs Therapeutics, Inc.
- Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments | Y-mAbs Therapeutics, Inc.
- Y-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024 | Y-mAbs Therapeutics, Inc.
- Y-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference | Y-mAbs Therapeutics, Inc.
- Y-mAbs Therapeutics Added to the NASDAQ Biotechnology Index | Y-mAbs Therapeutics, Inc.
- Y-mAbs Reports Third Quarter 2023 Financial Results and Recent Corporate Developments | Y-mAbs Therapeutics, Inc.
- Y-mAbs Names Michael Rossi as President and Chief Executive Officer and Director | Y-mAbs Therapeutics, Inc.
- View more press releases Close
Social media about Y-mAbs Therapeutics
- Y-mAbs Therapeutics on Wikipedia, Google News & Yahoo Finance
- Y-mAbs Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Sue Smith 
Call Y-mAbs Therapeutics at +1 646...
